The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Exogenous Aβ1–40 Reproduces Cerebrovascular Alterations Resulting from Amyloid Precursor Protein Overexpression in Mice
Open accessAbstract
Transgenic mice overexpressing the amyloid precursor protein (APP) have a profound impairment in endothelium-dependent cerebrovascular responses that is counteracted by the superoxide scavenger superoxide dismutase (SOD). The authors investigated whether the amyloid-β peptide (Aβ) is responsible for the cerebrovascular effects of APP overexpression. Cerebral blood flow (CBF) was monitored by a laser—Doppler flowmeter in anesthetized-ventilated mice equipped with a cranial window. Superfusion of Aβ1–40 on the neocortex reduced resting CBF in a dose-dependent fashion (−29% ± 7% at 5 μmol/L) and attenuated the increase in CBF produced by the endothelium-dependent vasodilators acetylcholine (−41% ± 8%), bradykinin (−39% ± 9%), and the calcium ionophore A23187 (−37% ± 5%). Aβ1–40 did not influence the CBF increases produced by the endothelium-independent vasodilators S-nitroso-N-acetylpenicillamine and hypercapnia. In contrast, Aβ1–42 did not attenuate resting CBF or the CBF increases produced by endothelium-dependent vasodilators. Cerebrovascular effects of Aβ1–40 were reversed by the superoxide scavengers SOD or MnTBAP. Furthermore, substitution of methionine 35 with norleucine, a mutation that blocks the ability of Aβ to generate reactive oxygen species, abolished Aβ1–40 vasoactivity. The authors conclude that Aβ1–40, but not Aβ1–42, reproduces the cerebrovascular alterations observed in APP transgenics, Thus, Aβ1–40 could play a role in the cerebrovascular alterations observed in Alzheimer's dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“evidence for this possibility comes from animal models in which exogenously applied or genetically overexpressed Aβ production diminished vasodilation to pharmacological or physiological stimuli, even in the absence of vascular Aβ deposits.115,160,161”
From Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2011) · cites this paper as [115]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In a variety of pathological conditions, including AD, cerebral amyloid angiopathy, and metabolic diseases such as type 2 diabetes and obesity, BACE1 expression and activity are increased and drive disease progression.”
From BACE1: More than just a β‐secretase (2022) · cites this paper as [39]
Experimental — accuracy not yet measuredIn the citing paper
“Pathologically elevated BACE1 expression in these cells has been implicated in the development of metabolic diseases, including type 2 diabetes, obesity, and cardiovascular disease.”
From BACE1: More than just a β‐secretase (2022) · cites this paper as [39]
In the citing paper
“Aβ is a potent vasoconstrictor113,114 and suppresses endothelium-dependent responses, functional hyperemia, and cerebrovascular autoregulation.115–117”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Sokoloff, L., Reivich, M., Kennedy, C., Rosiers, M. H. D., Patlak, C. S., Pettigrew, K. D., Sakurada, O., & Shinohara, M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10649.x · Cited by 6,000
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Purification and cloning of amyloid precursor protein β-secretase from human brain
Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., et al. (1999) · Nature · doi:10.1038/990114 · Cited by 1,612
Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity
Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashler, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., et al. (1999) · Nature · doi:10.1038/990107 · Cited by 1,438
Translating cell biology into therapeutic advances in Alzheimer's disease
Selkoe, D. J. (1999) · Nature · doi:10.1038/399a023 · Cited by 1,166
Cellular and molecular mechanisms of endothelial cell dysfunction.
Harrison, D. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119751 · Cited by 1,053
Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives
Mattson, M. P. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.4.1081 · Cited by 1,006 · cited 2×
“However, A[3 concentrations in the brains of patients with AD or APP mice are generally less (Hsiao et aI., 1995; Neve and Robakis, 1998) than those described to have cerebrovascular effects in the current study or to be neurotoxic in vitro (Mattson, 1997).”
BackgroundIn vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity
Pike, C. J., Walencewicz, A. J., Glabe, C. G., & Cotman, C. W. (1991) · Brain Research · doi:10.1016/0006-8993(91)91553-d · Cited by 828
Schmidt, A. M., Yan, S. D., Wautier, J.-L., & Stern, D. (1999) · Circulation Research · doi:10.1161/01.res.84.5.489 · Cited by 791
Research works printed but not linked: 3
- Day BJ, 1995, J Pharmacol Exp Ther, 275, 1227
- Iadecola C, 1994, Am J Physiol, 266, R518
- Stamler JS, 1996, Nature, 380, 108
Cited by
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Self-citationNeurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213
Self-citationThe Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
“…systemic blood vessels (Niwa et al., 2001; Paris et al., 2003; Thomas et al., 1996), whereas application of Ab1 40 to the exposed cerebral cortex of mice reduces CBF and impairs the increase in CBF induced by endothelium-dependent vasodilators and functional hyperemia (Niwa et al., 2000a; 2000b).”
Self-citationNeurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease
Girouard, H., & Iadecola, C. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00966.2005 · Cited by 1,265
Self-citationCerebral amyloid angiopathy in the elderly
Viswanathan, A., & Greenberg, S. M. (2011) · Annals of Neurology · doi:10.1002/ana.22516 · Cited by 643
Metadata
- Authors
- Niwa, K., Carlson, G. A., & Iadecola, C.
- Affiliations
- University of Minnesota (US)
- McLaughlin Research Institute (US)
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2000-12
- Volume
- 20
- Issue
- 12
- Pages
- 1659-1668
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W1992602428
- Cited by
- 191
- References
- 56
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 5 · 2023: 9 · 2022: 4 · 2021: 8 · 2020: 8 · 2019: 6 · 2018: 5 · 2017: 6 · 2016: 12 · 2015: 10 · 2014: 11 · 2013: 11 · 2012: 7
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (2r01ns038252-06, NS37853)
- National Institute of Neurological Disorders and Stroke (NS-37853, NS-38252, R01NS037853)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- Aβ40, amyloid-beta 42, amyloid precursor protein overexpression, APP transgenic mice, cerebrovascular dysfunction, cerebral blood flow, endothelium-dependent vasodilation, superoxide scavengers, superoxide dismutase, reactive oxygen species, Alzheimer's disease, neocortex
- MeSH terms
- Calcimycin, Acetylcholine, Animals, Autoradiography, Bradykinin, Brain, Cerebrovascular Circulation, Endothelium, Vascular, Glucose, Hypercapnia, Ionophores, Metalloporphyrins, Mice, Inbred C57BL, Mice, Transgenic, Penicillamine, Peptide Fragments, Superoxides, Superoxide Dismutase, Vasodilator Agents, Gene Expression, Free Radical Scavengers, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Laser-Doppler Flowmetry, Nitric Oxide Donors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exogenous Aβ1–40 Reproduces Cerebrovascular Alterations Resulting from Amyloid Precursor Protein Overexpression in Mice. https://app.cochat.ai/papers/10.1097/00004647-200012000-00005
- The paper
- Niwa, K., Carlson, G. A., & Iadecola, C. (2000). Exogenous Aβ1–40 Reproduces Cerebrovascular Alterations Resulting from Amyloid Precursor Protein Overexpression in Mice. Journal of Cerebral Blood Flow & Metabolism. https://doi.org/10.1097/00004647-200012000-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.